News

Labiotech. eu
labiotech. eu > in-depth > biotech-rebranding-new-names

New names, new narratives: Why biotechs decide to rebrand

5+ hour, 27+ min ago  (567+ words) Three recent examples illustrate just how different those transformations can be. While each company'emerged'with a new name and a new story to tell, the business realities behind those changes reveal three distinct approaches to reinvention.' Among the recent wave of…...

Symbols: nyse:lly,nasdaq:cnxu,nasdaq:pfai,nasdaq:bntx
Labiotech. eu
labiotech. eu > in-depth > university-vc-relations

How VCs and universities can unlock stronger collaboration

2+ mon, 9+ hour ago  (645+ words) The reality is at this early stage, the teams are just forming, and'it's'unclear what markets emerging technologies might have, and frankly,'that's'not what the researchers are here for. So,'I think there'is a little bit of a disconnect in end…...

Labiotech. eu
labiotech. eu > partner > bio-europe-startup-spotlight-lisbon-2026

Lisbon is calling: the BIO-Europe Startup Spotlight returns in March 2026

5+ mon, 4+ week ago  (594+ words) The Startup Spotlight is BIO-Europe's high-profile pitch competition specifically designed for emerging and early-stage biotechs. This year, German startup Fusix Biotech, led by CEO Jennifer Altomonte, took home the trophy ahead of seven other finalists, confirming the persuasiveness of their…...

Symbols: atmps,eif
Labiotech. eu
labiotech. eu > best-biotech > ai-biotech-deals-2025

The 2025 AI biotech deals every executive should watch

7+ mon, 2+ week ago  (841+ words) Along with receiving a $110 million upfront payment, CSPC is eligible to receive up to $1. 62 billion in potential development milestone payments and up to $3. 6 billion in sales milestone payments." According to Astra Zeneca, this collaboration further strengthens the big pharma's presence…...

Symbols: nasdaq:rlay,nasdaq:shph,pact